The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies
Open accessAbstract
Rationale: There is significant variation in approach to pre–lung transplant donor-specific antibodies (DSA), with some centers declining to cross any DSA. We implemented a protocol for transplantation for candidates with pretransplant DSA so long as a prospective complement-dependent cytotoxicity crossmatch was negative, regardless of number, specificity, class, or mean fluorescence intensity. Objectives: To compare post-transplant outcomes including overall survival, chronic lung allograft dysfunction–free survival, antibody-mediated rejection, and acute cellular rejection in lung transplant recipients where pretransplant DSA was and was not present. Methods: This was a single-center retrospective cohort study. For recipients with pretransplant DSA, if the prospective complement-dependent cytotoxicity crossmatch was negative, the donor offer was accepted and plasmapheresis was performed within 24 hours of transplantation and continued until retrospective crossmatch results returned. Immunosuppression and post-transplant management were not otherwise modified. Results: Of the 203 included recipients, 18 (8.9%) had pretransplant DSA. The median DSA mean fluorescence intensity was 4,000 (interquartile range, 2,975–5,625; total range, 2,100–17,000). The median number of DSA present per patient was one (interquartile range, 1–2). The presence of pretransplant DSA was not associated with increased mortality (hazard ratio, 1.2; 95% confidence interval [CI], 0.4–3.4) or decreased chronic lung allograft dysfunction–free survival (hazard ratio, 1.1; 95% CI, 0.6–2.1). Recipients with pretransplant DSA were more likely to require prolonged mechanical ventilation (adjusted odds ratio, 7.0; 95% CI, 2.3–21.6) and to have antibody-mediated rejection requiring treatment (adjusted odds ratio, 7.5; 95% CI, 1.0–55.8). Conclusions: A protocol of accepting donor offers for lung transplant candidates with preformed, complement-dependent cytotoxicity crossmatch-negative DSA is associated with increased need for prolonged mechanical ventilation and antibody-mediated rejection without affecting short-term overall or chronic lung allograft dysfunction–free survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevated HLA specific antibodies detected in peripheral blood may make finding a compatible donor difficult and may predict poor outcomes.(59–61)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Elevated HLA specific antibodies detected in peripheral blood may make finding a compatible donor difficult and may predict poor outcomes.(59–61)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tait, B. D., Süsal, C., Gebel, H. M., Nickerson, P. W., Zachary, A. A., Claas, F. H. J., Reed, E. F., Bray, R. A., Campbell, P., Chapman, J. R., et al. (2013) · Transplantation · doi:10.1097/tp.0b013e31827a19cc · Cited by 787
A new classification system for chronic lung allograft dysfunction
Verleden, G. M., Raghu, G., Meyer, K. C., Glanville, A. R., & Corris, P. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.10.022 · Cited by 503
Levine, D. J., Glanville, A. R., Aboyoun, C., Belperio, J., Benden, C., Berry, G. J., Hachem, R., Hayes, D., Neil, D., Reinsmoen, N. L., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.01.1223 · Cited by 488
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report
Tambur, A. R., Campbell, P., Claas, F. H., Feng, S., Gebel, H. M., Jackson, A. M., Mannon, R. B., Reed, E. F., Tinckam, K., Askar, M., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14752 · Cited by 297
Self-citationHachem, R. R., Yusen, R. D., Meyers, B. F., Aloush, A. A., Mohanakumar, T., Patterson, G. A., & Trulock, E. P. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.006 · Cited by 235
Tikkanen, J. M., Singer, L. G., Kim, S. J., Li, Y., Binnie, M., Chaparro, C., Chow, C.-W., Martinu, T., Azad, S., Keshavjee, S., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1857oc · Cited by 186
Survival in Sensitized Lung Transplant Recipients With Perioperative Desensitization
Tinckam, K. J., Keshavjee, S., Chaparro, C., Barth, D., Azad, S., Binnie, M., Chow, C. W., de Perrot, M., Pierre, A. F., Waddell, T. K., et al. (2015) · American Journal of Transplantation · doi:10.1111/ajt.13076 · Cited by 161
Burton, C. M., Iversen, M., Carlsen, J., Mortensen, J., Andersen, C. B., Steinbrüchel, D. A., & Scheike, T. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2009.04.022 · Cited by 146
Roux, A., Lan, I. B. L., Holifanjaniaina, S., Thomas, K. A., Hamid, A. M., Picard, C., Grenet, D., de Miranda, S., Douvry, B., Beaumont, L., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13589 · Cited by 143
Safavi, S., Robinson, D., Soresi, S., Carby, M. R., & Smith, J. D. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.07.012 · Cited by 129
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Lefaucheur, C., Louis, K., Morris, A. B., Taupin, J., Nickerson, P. W., Tambur, A. R., Gebel, H. M., Reed, E. F., KOBASHIGAWA, J. A., Chandraker, A. K., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2022.11.013 · Cited by 116
Christie, J. D., Raemdonck, D. E. V., & Fisher, A. J. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2401039 · Cited by 124
Antibody-mediated rejection after lung transplantation
Bery, A. I., & Hachem, R. R. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.86 · Cited by 73
Metadata
- Authors
- Courtwright, A. M., Cao, S., Wood, I., Mallidi, H. R., Kawasawa, J., Moniodis, A., Ng, J., El-Chemaly, S., & Goldberg, H. J.
- Affiliations
- Hospital of the University of Pennsylvania (US)
- Department of Medicine
- Clinical Laboratory Division, Tissue Typing Laboratory
- Lung Transplant Program, Division of Thoracic Surgery
- University of Washington (US)
- Stamford Hospital (US)
- Division of Pulmonary and Critical Care Medicine, and
- Lung Transplant Program, Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, Massachusetts
- Brigham and Women's Hospital (US)
- Corresponding author
- Goldberg, Hilary J.
- Venue
- Annals of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-09-01
- Volume
- 16
- Issue
- 9
- Pages
- 1131-1137
- ISSN
- 2325-6621 (ISSN-L)
- 2329-6933
- PMC
- PMC6850801
- OpenAlex
- W2940553959
- Semantic Scholar
- e06e1bc74bf904e0086305f5768959c2db2252ee
- Cited by
- 39
- References
- 20
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 4 · 2023: 10 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 1
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the American Thoracic Society (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL130275, T32HL007633)
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Keywords
- lung transplantation, donor-specific antibodies, complement-dependent cytotoxicity crossmatch, antibody-mediated rejection, acute cellular rejection, chronic lung allograft dysfunction, plasmapheresis, mechanical ventilation, overall survival, immunosuppression
- MeSH terms
- Aged, Boston, Female, Graft Rejection, Graft Survival, Histocompatibility Testing, HLA Antigens, Humans, Isoantibodies, Male, Middle Aged, Retrospective Studies, Tissue Donors, Proportional Hazards Models, Lung Transplantation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies. https://app.cochat.ai/papers/10.1513/annalsats.201812-869oc
- The paper
- Courtwright, A. M., Cao, S., Wood, I., Mallidi, H. R., Kawasawa, J., Moniodis, A., Ng, J., El-Chemaly, S., & Goldberg, H. J. (2019). Clinical Outcomes of Lung Transplantation in the Presence of Donor-Specific Antibodies. Annals of the American Thoracic Society. https://doi.org/10.1513/annalsats.201812-869oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.